Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.